Skip to main content
AMN
NYSE Trade & Services

AMN Beats Q3 Guidance but Guides Q4 Revenue Down 10-12% as Labor Disruption Fades

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$49.05
Mkt Cap
$1.837B
52W Low
$14.97
52W High
$49.62
52W Position info
228% above low
Off High info
1.1% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

AMN has more than doubled off its 52-week low of $14.97.

Summary

AMN beat Q3 guidance with $717M revenue and $1.16 adjusted EPS, but guided Q4 revenue 10-12% lower year over year as labor disruption revenue drops to ~$5M from $124M.


Key Events · Earnings and Guidance · AMN

  • Q3 Beats Guidance

    Revenue of $717.3M rose 13% year over year and 7% sequentially; adjusted diluted EPS of $1.16 versus $0.39 a year ago and GAAP EPS of $0.83.

  • Q4 Revenue Guided Down 10-12%

    Q4 revenue outlook of $655-$670M assumes labor disruption revenue of just $5M versus $124M in Q4 2025; adjusted EBITDA margin guided to 5.8%-6.3% from 13.0% in Q3.

  • Core Nurse Staffing Still Growing

    Excluding labor disruption, Nurse and Allied revenue is guided up 13-15% year over year in Q4; Q3 travel nurse revenue rose 19% year over year.

  • Cash Flow Turns Negative on Deposit Refunds

    Q3 operating cash flow was negative $88M as the company refunded the majority of client deposits tied to prior labor disruption events; cash ended at $256M.


Analysis · AMN · Trade & Services

Q3 was strong: revenue of $717M and adjusted EPS of $1.16 both exceeded guidance, helped by a labor disruption reserve release and double-digit travel nurse volume growth. What comes next is the problem. Q4 revenue is guided to $655-$670M, 10-12% below last year, because labor disruption revenue collapses to about $5M from $124M a year ago. Strip that out and Nurse and Allied is still guided up 13-15%, so the core staffing recovery is intact. But the headline numbers step down hard, and Q3 operating cash flow was negative $88M after refunding client deposits. The balance sheet is the offset: leverage fell to 1.3x from 3.3x, with $256M of cash and nothing drawn on the revolver.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, AMN was trading at $49.05 on NYSE in the Trade & Services sector, with a market capitalization of approximately $1.8B. The 52-week trading range was $14.97 to $49.62. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AMN - Latest Insights

AMN
Nov 05, 2026, 4:15 PM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $49.05
Real-time Price: $35.68 info
Change: -$13.37 (-27%) info
Market Cap: $1.376B info
AMN
Aug 06, 2026, 6:10 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $32.90
Real-time Price: $35.68 info
Change: +$2.78 (+8%) info
Market Cap: $1.376B info
AMN
Jun 24, 2026, 10:42 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $31.22
Real-time Price: $35.68 info
Change: +$4.47 (+14%) info
Market Cap: $1.376B info
AMN
Jun 09, 2026, 9:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $31.39
Real-time Price: $35.68 info
Change: +$4.29 (+14%) info
Market Cap: $1.376B info
AMN
May 07, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $23.96
Real-time Price: $35.68 info
Change: +$11.72 (+49%) info
Market Cap: $1.376B info